Genomics specialist Geneservice announces management buyout from the Medical Research Council

Geneservice will inherit from the MRC more than 10 years pedigree as a biological resource centre and innovative genomics services provider. The company will occupy a unique position, rapidly identifying potential services and products arising from the multitude of genomics projects worldwide and making them available to the genomic research community. A wide international customer base including leading research centres and pharmaceutical companies has already been built. Geneservice's one-stop service for genomics researchers is highly regarded for its quality, turnaround time and competitive pricing. The continuing mission of Geneservice will be to provide an archiving and distribution portal for emerging genomic reagents, such as bacterial clones and Human DNA samples, generated by academic groups and consortia internationally. The new entity will also provide access to state-of-the-art high throughput technologies for the study of gene expression and gene mapping, including disease gene identification. Likewise, the initial product portfolio includes genomic clones from a wide range of organisms in various formats. The Geneservice range of services includes DNA sequencing, micro satellite and SNP genotyping, whole genome amplification and RNA expression profiling.